Tag Archives: Biosimilar and Biologics Market

Biosimilar and Biologics Market to Reach USD 1,157.4B by 2035 at 7.6% CAGR

The global biosimilar and biologics market is projected to grow from USD 561.7 billion in 2025 to USD 1,157.4 billion by 2035, registering a robust CAGR of 7.6% over the forecast period. This impressive expansion is being driven by rising global demand for targeted therapies, increasing prevalence of chronic diseases, and the accelerated regulatory approvals …

Continue reading “Biosimilar and Biologics Market to Reach USD 1,157.4B by 2035 at 7.6% CAGR”

Biosimilar and Biologics Market to Total USD 1,060.7 Billion by 2034 Amid Rising Prevalence of Chronic Diseases and Growing Need for Affordable Treatments | FMI

As per the latest analysis, the biosimilar and biologics market value is estimated to reach USD 520.9 billion in 2024. Global sales of biosimilars and biologics will likely increase at 7.6% CAGR during the forecast period, taking the overall market valuation to a staggering USD 1,060.7 billion by 2034. The monoclonal antibody segment is expected …

Continue reading “Biosimilar and Biologics Market to Total USD 1,060.7 Billion by 2034 Amid Rising Prevalence of Chronic Diseases and Growing Need for Affordable Treatments | FMI”